BioSphere Medical to Broadcast Fourth-Quarter and Year-End 2000 Conference Call Over the Internet.Business/Technology Editors and Medical Writers ROCKLAND Rockland, industrial town (1990 pop. 16,123), Plymouth co., E Mass.; settled 1673, set off from Abington and inc. 1874. There is light manufacturing. , Mass.--(BUSINESS WIRE)--Jan. 12, 2001 BioSphere biosphere, irregularly shaped envelope of the earth's air, water, and land encompassing the heights and depths at which living things exist. The biosphere is a closed and self-regulating system (see ecology), sustained by grand-scale cycles of energy and of Medical (Nasdaq: BSMD), a medical device company that is pioneering the use of bioengineered microspheres in embolotherapy, plans to announce its fourth-quarter and year-end 2000 financial results before the market opens on Thursday, January 18, 2001. The company will conduct its quarterly conference call at 11:00 a.m. (ET) on Thursday, January 18. The conference call will be broadcast live over the Internet Internet Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the . Investors interested in listening to the call should log onto the company's Web site at www.biospheremed.com at least 15 minutes prior to the broadcast. Investors can also access an archived version of the call on the company's Web site. About BioSphere Medical, Inc. BioSphere Medical, Inc., based in Rockland, Massachusetts Rockland is a town in Plymouth County, Massachusetts, United States. The population was 17,670 at the 2000 census. with 10,199 total registered voters as of December 31, 2005. , is a medical device company focused on embolotherapy, the treatment of tumors and vascular malformations Vascular malformation A poorly formed blood or lymph vessels. Mentioned in: Birthmarks by occluding their blood supply. The company is pioneering the use of patented and proprietary bioengineered Microspheres as a new class of embolics. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion